Last reviewed · How we verify

NCT06847945

Observation on the Curative Effect of Acupuncture At Sensitized Points on Gallbladder Meridian in the Treatment of Neck Type Cervical Spondylopathy

Not yet recruiting NA Last updated 26 February 2025
What this trial tests

NA trial testing Sham acupuncture in Cervical Spondylopathy in 80 participants. Not yet recruiting.

Timeline
5 March 2025
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorLiChaoran
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment80
Start date5 March 2025
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

LiChaoran

Who can join

Adults 18 to 65, any sex, with Cervical Spondylopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the changes of acupoint sensitization characteristics of patients with Neck Type Cervical Spondylopathy through Gallbladder meridian observe the curative effect of acupuncture intervention and optimize the clinical diagnosis and treatment plan of acupuncture treatment of Neck Type Cervical Spondylopathy

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Acupuncture at Sensitized Acupoints versus Sham Acupuncture for Neck-Type Cervical Spondylosis: Study Protocol for a Randomized Controlled Trial.
    Li C, Wang J, Shao X, Wu Y, et al · · 2025 · PMID 41458188 · DOI 10.2147/jpr.s548317

Verify or expand the search:

Other trials of Sham acupuncture

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06847945.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing